Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women.

Gupta A, Montepiedra G, Aaron L, Theron G, McCarthy K, Bradford S, Chipato T, Vhembo T, Stranix-Chibanda L, Onyango-Makumbi C, Masheto GR, Violari A, Mmbaga BT, Aurpibul L, Bhosale R, Mave V, Rouzier V, Hesseling A, Shin K, Zimmer B, Costello D, Sterling TR, Chakhtoura N, Jean-Philippe P, Weinberg A; IMPAACT P1078 TB APPRISE Study Team.

N Engl J Med. 2019 Oct 3;381(14):1333-1346. doi: 10.1056/NEJMoa1813060.

PMID:
31577875
2.

Risk Factors for Adverse Birth Outcomes in the PROMISE 1077BF/1077FF Trial.

Sebikari D, Farhad M, Fenton T, Owor M, Stringer JSA, Qin M, Chakhtoura N, Chi BH, Saidi F, Nevrekar N, Violari A, Chipato T, McIntyre JA, Moodley D, Taha TE, Theron G, Fowler MG.

J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):521-532. doi: 10.1097/QAI.0000000000002072.

PMID:
31295174
3.

Correction: Abortion in Zimbabwe: A national study of the incidence of induced abortion, unintended pregnancy and post-abortion care in 2016.

Sully EA, Madziyire MG, Riley T, Moore AM, Crowell M, Nyandoro MT, Madzima B, Chipato T.

PLoS One. 2019 May 30;14(5):e0217735. doi: 10.1371/journal.pone.0217735. eCollection 2019.

4.

Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial.

Hoffman RM, Angelidou KN, Brummel SS, Saidi F, Violari A, Dula D, Mave V, Fairlie L, Theron G, Kamateeka M, Chipato T, Chi BH, Stranix-Chibanda L, Nematadzira T, Moodley D, Bhattacharya D, Gupta A, Coletti A, McIntyre JA, Klingman KL, Chakhtoura N, Shapiro DE, Fowler MG, Currier JS; IMPAACT PROMISE 1077BF/FF team.

HIV Clin Trials. 2018 Dec;19(6):209-224. doi: 10.1080/15284336.2018.1537327.

5.

The multi-country PROMOTE HIV antiretroviral treatment observational cohort in Sub-Saharan Africa: Objectives, design, and baseline findings.

Taha TE, Yende-Zuma N, Aizire J, Chipato T, Wambuzi Ogwang L, Makanani B, Chinula L, Nyati MM, Hanley S, Brummel SS, Fowler MG.

PLoS One. 2018 Dec 13;13(12):e0208805. doi: 10.1371/journal.pone.0208805. eCollection 2018.

6.

Prevention of cervical cancer in HIV-seropositive women from developing countries through cervical cancer screening: a systematic review.

Mapanga W, Girdler-Brown B, Feresu SA, Chipato T, Singh E.

Syst Rev. 2018 Nov 17;7(1):198. doi: 10.1186/s13643-018-0874-7.

7.

Abortion in Zimbabwe: A national study of the incidence of induced abortion, unintended pregnancy and post-abortion care in 2016.

Sully EA, Madziyire MG, Riley T, Moore AM, Crowell M, Nyandoro MT, Madzima B, Chipato T.

PLoS One. 2018 Oct 24;13(10):e0205239. doi: 10.1371/journal.pone.0205239. eCollection 2018. Erratum in: PLoS One. 2019 May 30;14(5):e0217735.

8.

A Longitudinal Assessment of Cervical Inflammation and Immunity Associated with HIV-1 Infection, Hormonal Contraception, and Pregnancy.

Morrison CS, Fichorova R, Chen PL, Kwok C, Deese J, Yamamoto H, Anderson S, Chipato T, Salata R, Doncel GF.

AIDS Res Hum Retroviruses. 2018 Oct;34(10):889-899. doi: 10.1089/AID.2018.0022. Epub 2018 Sep 5.

9.

Rationale and design of a multi-center, open-label, randomised clinical trial comparing HIV incidence and contraceptive benefits in women using three commonly-used contraceptive methods (the ECHO study).

Hofmeyr GJ, Morrison CS, Baeten JM, Chipato T, Donnell D, Gichangi P, Mugo N, Nanda K, Rees H, Steyn P, Taylor D; ECHO Trial Team.

Version 2. Gates Open Res. 2018 Mar 13 [revised 2018 Jan 1];1:17. doi: 10.12688/gatesopenres.12775.2. eCollection 2017.

10.

Severity and management of postabortion complications among women in Zimbabwe, 2016: a cross-sectional study.

Madziyire MG, Polis CB, Riley T, Sully EA, Owolabi O, Chipato T.

BMJ Open. 2018 Feb 10;8(2):e019658. doi: 10.1136/bmjopen-2017-019658.

11.

Treatment of cervical cancer in HIV-seropositive women from developing countries: a protocol for a systematic review.

Mapanga W, Chipato T, Feresu SA.

Syst Rev. 2018 Jan 25;7(1):22. doi: 10.1186/s13643-018-0686-9. Review.

12.

Higher sequence diversity in the vaginal tract than in blood at early HIV-1 infection.

Klein K, Nickel G, Nankya I, Kyeyune F, Demers K, Ndashimye E, Kwok C, Chen PL, Rwambuya S, Poon A, Munjoma M, Chipato T, Byamugisha J, Mugyenyi P, Salata RA, Morrison CS, Arts EJ.

PLoS Pathog. 2018 Jan 18;14(1):e1006754. doi: 10.1371/journal.ppat.1006754. eCollection 2018 Jan.

13.

Prevention of cervical cancer in HIV-seropositive women from developing countries: a systematic review protocol.

Mapanga W, Elhakeem A, Feresu SA, Maseko F, Chipato T.

Syst Rev. 2017 Apr 24;6(1):91. doi: 10.1186/s13643-017-0484-9.

14.

Short Communication: Comparison of Maxim and Sedia Limiting Antigen Assay Performance for Measuring HIV Incidence.

Schlusser KE, Konikoff J, Kirkpatrick AR, Morrison C, Chipato T, Chen PL, Munjoma M, Eshleman SH, Laeyendecker O.

AIDS Res Hum Retroviruses. 2017 Jun;33(6):555-557. doi: 10.1089/aid.2016.0245. Epub 2017 Mar 20.

15.

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention.

Fowler MG, Qin M, Fiscus SA, Currier JS, Flynn PM, Chipato T, McIntyre J, Gnanashanmugam D, Siberry GK, Coletti AS, Taha TE, Klingman KL, Martinson FE, Owor M, Violari A, Moodley D, Theron GB, Bhosale R, Bobat R, Chi BH, Strehlau R, Mlay P, Loftis AJ, Browning R, Fenton T, Purdue L, Basar M, Shapiro DE, Mofenson LM; IMPAACT 1077BF/1077FF PROMISE Study Team.

N Engl J Med. 2016 Nov 3;375(18):1726-1737.

16.

An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women.

Polis CB, Curtis KM, Hannaford PC, Phillips SJ, Chipato T, Kiarie JN, Westreich DJ, Steyn PS.

AIDS. 2016 Nov 13;30(17):2665-2683. Review.

17.

Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan Africa.

Venner CM, Nankya I, Kyeyune F, Demers K, Kwok C, Chen PL, Rwambuya S, Munjoma M, Chipato T, Byamugisha J, Van Der Pol B, Mugyenyi P, Salata RA, Morrison CS, Arts EJ.

EBioMedicine. 2016 Nov;13:305-314. doi: 10.1016/j.ebiom.2016.10.014. Epub 2016 Oct 12.

18.

Serum vitamin D status and bacterial vaginosis prevalence and incidence in Zimbabwean women.

Turner AN, Carr Reese P, Chen PL, Kwok C, Jackson RD, Klebanoff MA, Fichorova RN, Chipato T, Morrison CS.

Am J Obstet Gynecol. 2016 Sep;215(3):332.e1-332.e10. doi: 10.1016/j.ajog.2016.02.045. Epub 2016 Mar 2.

19.

Biomarkers of Cervical Inflammation and Immunity Associated with Cervical Shedding of HIV-1.

Mauck C, Chen PL, Morrison CS, Fichorova RN, Kwok C, Chipato T, Salata RA, Doncel GF.

AIDS Res Hum Retroviruses. 2016 May;32(5):443-51. doi: 10.1089/AID.2015.0088. Epub 2016 Jan 26.

20.

The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.

Fichorova RN, Chen PL, Morrison CS, Doncel GF, Mendonca K, Kwok C, Chipato T, Salata R, Mauck C.

MBio. 2015 Sep 1;6(5):e00221-15. doi: 10.1128/mBio.00221-15.

21.

Introducing misoprostol for the management of postpartum hemorrhage in Zimbabwe: final report on operational research.

Zvandasara P, Chipato T, Mawere E, Rivelt K, McNally T.

Cent Afr J Med. 2015 Sep-Dec;61(9-12):76-83. Review.

PMID:
29144067
22.

Perceptions of misoprostol among providers and women seeking post-abortion care in Zimbabwe.

Maternowska MC, Mashu A, Moyo P, Withers M, Chipato T.

Reprod Health Matters. 2015 Feb;22(44 Suppl 1):16-25. doi: 10.1016/S0968-8080(14)43792-3.

23.

Mycoplasma genitalium is associated with increased genital HIV type 1 RNA in Zimbabwean women.

Napierala Mavedzenge S, Müller EE, Lewis DA, Chipato T, Morrison CS, Weiss HA.

J Infect Dis. 2015 May 1;211(9):1388-98. doi: 10.1093/infdis/jiu644. Epub 2014 Nov 17.

PMID:
25404521
24.

Cessation of intravaginal practices to prevent bacterial vaginosis: a pilot intervention in Zimbabwean women.

Esber A, Moyo P, Munjoma M, Francis S, van de Wijgert J, Chipato T, Turner AN.

Sex Transm Infect. 2015 May;91(3):183-8. doi: 10.1136/sextrans-2014-051764. Epub 2014 Oct 29.

PMID:
25355772
25.

Interest in multipurpose prevention of HIV and pregnancy: perspectives of women, men, health professionals and community stakeholders in two vaginal gel studies in southern Africa.

Woodsong C, Musara P, Chandipwisa A, Montgomery E, Alleman P, Chirenje M, Chipato T, Martinson F, Hoffman I.

BJOG. 2014 Oct;121 Suppl 5:45-52. doi: 10.1111/1471-0528.12875.

26.

The association between the ratio of monocytes: lymphocytes and risk of tuberculosis among HIV-infected postpartum women.

Naranbhai V, Moodley D, Chipato T, Stranix-Chibanda L, Nakabaiito C, Kamateeka M, Musoke P, Manji K, George K, Emel LM, Richardson P, Andrew P, Fowler M, Fletcher H, McShane H, Coovadia HM, Hill AV; HPTN 046 Protocol Team.

J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):573-5. doi: 10.1097/QAI.0000000000000353.

27.

Optimization of the oligonucleotide ligation assay for the detection of nevirapine resistance mutations in Zimbabwean Human Immunodeficiency Virus type-1 subtype C.

Mutsvangwa J, Beck IA, Gwanzura L, Manhanzva MT, Stranix-Chibanda L, Chipato T, Frenkel LM.

J Virol Methods. 2014 Dec 15;210:36-9. doi: 10.1016/j.jviromet.2014.09.005. Epub 2014 Sep 17.

28.

Clinicians' perceptions and provision of hormonal contraceptives for HIV-positive and at-risk women in Southern Africa: an original research article.

Blanchard K, Chipato T, Ramjee G, Nhemachena T, Harper CC; Provider Study Writing Comittee.

Contraception. 2014 Oct;90(4):391-8. doi: 10.1016/j.contraception.2014.04.010. Epub 2014 May 4.

29.

Cervical inflammation and immunity associated with hormonal contraception, pregnancy, and HIV-1 seroconversion.

Morrison C, Fichorova RN, Mauck C, Chen PL, Kwok C, Chipato T, Salata R, Doncel GF.

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):109-17. doi: 10.1097/QAI.0000000000000103.

PMID:
24413042
30.

Integrating family planning and prevention of mother to child HIV transmission in Zimbabwe.

Sarnquist CC, Moyo P, Stranix-Chibanda L, Chipato T, Kang JL, Maldonado YA.

Contraception. 2014 Mar;89(3):209-14. doi: 10.1016/j.contraception.2013.11.003. Epub 2013 Nov 12.

31.

Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial.

Laeyendecker O, Kulich M, Donnell D, Komárek A, Omelka M, Mullis CE, Szekeres G, Piwowar-Manning E, Fiamma A, Gray RH, Lutalo T, Morrison CS, Salata RA, Chipato T, Celum C, Kahle EM, Taha TE, Kumwenda NI, Karim QA, Naranbhai V, Lingappa JR, Sweat MD, Coates T, Eshleman SH.

PLoS One. 2013 Nov 13;8(11):e78818. doi: 10.1371/journal.pone.0078818. eCollection 2013.

32.

Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial.

Fowler MG, Coovadia H, Herron CM, Maldonado Y, Chipato T, Moodley D, Musoke P, Aizire J, Manji K, Stranix-Chibanda L, Fawzi W, Chetty V, Msweli L, Kisenge R, Brown E, Mwatha A, Eshleman SH, Richardson P, Allen M, George K, Andrew P, Zwerski S, Mofenson LM, Jackson JB; HPTN 046 Protocol Team.

J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):366-74. doi: 10.1097/QAI.0000000000000052.

33.

Differences in Clinical Manifestations of Acute and Early HIV-1 Infection between HIV-1 Subtypes in African Women.

Lemonovich TL, Watkins RR, Morrison CS, Kwok C, Chipato T, Musoke R, Arts EJ, Nankya I, Salata RA.

J Int Assoc Provid AIDS Care. 2015 Sep-Oct;14(5):415-22. doi: 10.1177/2325957413504827. Epub 2013 Oct 8.

34.

HIV disease progression in the first year after delivery among African women followed in the HPTN 046 clinical trial.

Watts DH, Brown ER, Maldonado Y, Herron C, Chipato T, Reddy L, Moodley D, Nakabiito C, Manji K, Fawzi W, George K, Richardson P, Zwerski S, Coovadia H, Fowler M; HPTN 046 Protocol Team.

J Acquir Immune Defic Syndr. 2013 Nov 1;64(3):299-306. doi: 10.1097/QAI.0b013e3182a2123a.

35.

Provision of long-acting reversible contraception in HIV-prevalent countries: results from nationally representative surveys in southern Africa.

Morse J, Chipato T, Blanchard K, Nhemachena T, Ramjee G, McCulloch C, Blum M, Saleeby E, Harper CC.

BJOG. 2013 Oct;120(11):1386-94. doi: 10.1111/1471-0528.12290. Epub 2013 May 31.

36.

Hormonal contraceptive use and discontinuation among HIV-infected women in Uganda and Zimbabwe.

Bengtson A, Kwok C, Salata RA, Byamugisha J, Chipato T, Rwambuya S, Moyo P, Morrison CS.

J Acquir Immune Defic Syndr. 2013 Aug 1;63(4):506-13. doi: 10.1097/QAI.0b013e318293df9e.

37.

A nationally representative survey of healthcare provider counselling and provision of the female condom in South Africa and Zimbabwe.

Holt K, Blanchard K, Chipato T, Nhemachena T, Blum M, Stratton L, Morar N, Ramjee G, Harper CC.

BMJ Open. 2013 Mar 18;3(3). pii: e002208. doi: 10.1136/bmjopen-2012-002208.

38.

Impact of maternal and infant antiretroviral drug regimens on drug resistance in HIV-infected breastfeeding infants.

Fogel JM, Mwatha A, Richardson P, Brown ER, Chipato T, Alexandre M, Moodley D, Elbireer A, Mirochnick M, George K, Mofenson LM, Zwerski S, Coovadia HM, Eshleman SH.

Pediatr Infect Dis J. 2013 Apr;32(4):e164-9. doi: 10.1097/INF.0b013e31827f44ee.

39.

Diaphragm used with replens gel and risk of bacterial vaginosis: results from a randomized controlled trial.

Cohen CR, Cheng SC, Shiboski S, Chipato T, Matu M, Mwangi J, Mutimutema ME, Tuveson J, Kamba M, Padian N, van der Straten A.

Infect Dis Obstet Gynecol. 2012;2012:921519. doi: 10.1155/2012/921519. Epub 2012 Oct 24.

40.

Discrepancies in diagnosis of incident HIV infection between antibody- and DNA-based tests in a phase III prevention trial in southern Africa.

Montgomery ET, van der Pol B, van der Straten A, Ramjee G, de Bruyn G, Chipato T, Blanchard K, Padian NS; MIRA Team.

Int J STD AIDS. 2012 Sep;23(9):649-52. doi: 10.1258/ijsa.2009.009124.

PMID:
23033520
41.

Progress, challenges, and new opportunities for the prevention of mother-to-child transmission of HIV under the US President's Emergency Plan for AIDS Relief.

Chi BH, Adler MR, Bolu O, Mbori-Ngacha D, Ekouevi DK, Gieselman A, Chipato T, Luo C, Phelps BR, McClure C, Mofenson LM, Stringer JS.

J Acquir Immune Defic Syndr. 2012 Aug 15;60 Suppl 3:S78-87. doi: 10.1097/QAI.0b013e31825f3284. Review.

PMID:
22797744
42.

Sharing the trousers: gender roles and relationships in an HIV-prevention trial in Zimbabwe.

Montgomery ET, Chidanyika A, Chipato T, van der Straten A.

Cult Health Sex. 2012;14(7):795-810. doi: 10.1080/13691058.2012.697191. Epub 2012 Jul 9.

PMID:
22776060
43.

Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial.

Lockman S, Hughes M, Sawe F, Zheng Y, McIntyre J, Chipato T, Asmelash A, Rassool M, Kimaiyo S, Shaffer D, Hosseinipour M, Mohapi L, Ssali F, Chibowa M, Amod F, Halvas E, Hogg E, Alston-Smith B, Smith L, Schooley R, Mellors J, Currier J; OCTANE (Optimal Combination Therapy After Nevirapine Exposure) ACTG A5208/OCTANE Study Team.

PLoS Med. 2012;9(6):e1001236. doi: 10.1371/journal.pmed.1001236. Epub 2012 Jun 12.

44.

Male circumcision for HIV prevention: clinical practices and attitudes among healthcare providers in South Africa and Zimbabwe.

Sheldon WR, Nhemachena T, Blanchard K, Chipato T, Ramjee G, Trussell J, McCulloch CE, Blum M, Harper CC.

Sex Transm Dis. 2012 Jul;39(7):567-75. doi: 10.1097/OLQ.0b013e31824f9eaf.

45.

The frequency of malaria is similar among women receiving either lopinavir/ritonavir or nevirapine-based antiretroviral treatment.

Skinner-Adams TS, Butterworth AS, Porter KA, D'Amico R, Sawe F, Shaffer D, Siika A, Hosseinipour MC, Stringer E, Currier JS, Chipato T, Salata R, Lockman S, Eron JJ, Meshnick SR, McCarthy JS.

PLoS One. 2012;7(4):e34399. doi: 10.1371/journal.pone.0034399. Epub 2012 Apr 3.

46.

Incidence of major clinical outcomes in a cohort of Ugandan and Zimbabwean women with HIV-1 infection followed from seroconversion.

Beversluis D, Musoke R, Mandima P, Nyamapfeni P, Chipato T, Mukasa JB, Byamugisha J, Mugerwa R, Morrison C, Salata RA.

Int J STD AIDS. 2012 Feb;23(2):111-4. doi: 10.1258/ijsa.2011.011117. Erratum in: Int J STD AIDS. 2012 Aug;132(2):1230.

PMID:
22422685
47.

Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa.

Pantazis N, Morrison C, Amornkul PN, Lewden C, Salata RA, Minga A, Chipato T, Jaffe H, Lakhi S, Karita E, Porter K, Meyer L, Touloumi G; CASCADE Collaboration in EuroCoord and ANRS 1220 Primo-CI Study Group.

PLoS One. 2012;7(3):e32369. doi: 10.1371/journal.pone.0032369. Epub 2012 Mar 6.

48.

The association between Mycoplasma genitalium and HIV-1 acquisition in African women.

Mavedzenge SN, Van Der Pol B, Weiss HA, Kwok C, Mambo F, Chipato T, Van der Straten A, Salata R, Morrison C.

AIDS. 2012 Mar 13;26(5):617-24. doi: 10.1097/QAD.0b013e32834ff690.

PMID:
22210630
49.

Willingness of clinicians to integrate microbicides into HIV prevention practices in southern Africa.

Harper CC, Holt K, Nhemachena T, Chipato T, Ramjee G, Stratton L, Blum M, McCulloch CE, Mgweba S, Blanchard K.

AIDS Behav. 2012 Oct;16(7):1821-9.

50.

Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial.

Coovadia HM, Brown ER, Fowler MG, Chipato T, Moodley D, Manji K, Musoke P, Stranix-Chibanda L, Chetty V, Fawzi W, Nakabiito C, Msweli L, Kisenge R, Guay L, Mwatha A, Lynn DJ, Eshleman SH, Richardson P, George K, Andrew P, Mofenson LM, Zwerski S, Maldonado Y; HPTN 046 protocol team.

Lancet. 2012 Jan 21;379(9812):221-8. doi: 10.1016/S0140-6736(11)61653-X. Epub 2011 Dec 22.

Supplemental Content

Loading ...
Support Center